Investigation of the Effects of Different Exercise on Wound Healing in Patients wıth Diabetic Foot Wounds

July 18, 2023 updated by: Fatih Enzin, Harran University

Investigation of the Effect of Different Exercise Training on Wound Healing ın Patients With Diabetic Foot Ulcer

Exercise studies with patients with diabetic foot ulcers are very few. In this disease group, since it is considered dangerous to put a load on the foot, a barrier has been placed between the patients and the exercise. With the study investigators plan to do, investigators will try to exercise in these patients in a controlled manner. Among the patients divided into 3 groups, the 1st group will apply the control group, the 2nd group will perform aerobic exercise, and the 3rd group will apply the exercises investigators have determined as the protocol group. 12 weeks, 2 sessions a week will be exercised with the help of a physiotherapist. Patients will be evaluated at baseline, at the end of week 4, at the end of week 8, and at the end.

Study Overview

Study Type

Interventional

Enrollment (Actual)

51

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Şanlıurfa, Turkey
        • Harran Unıversıty

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

35 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Having been diagnosed with Type II diabetes and having a foot ulcer
  • Being in the 1st or 2nd category according to the Wagner classification
  • Not to have a serious musculoskeletal, cardiac, neurological, etc. systemic disease that may interfere with the research.
  • Not having any communication problems
  • Having the same wound care procedure
  • Not taking any other treatment that may have an effect on the wound.

Exclusion Criteria:

  • Individuals with a diagnosed psychiatric illness,
  • Individuals who have received any physiotherapy treatment in the last 3 months,
  • Individuals with acute infection,
  • Individuals with toe pressure < 40 mmHg
  • Individuals with Charcot Foot and/or osteomyelitis
  • Individuals with venous ulcer disease
  • Individuals who are morbidly obese (BMI >40) according to body mass index
  • Individuals with incurable proliperative retinopathy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: exercise protocol group
The group that applied progressive exercise according to the motivation of patients and healing status of ulcers.
The protocol exercise group will be provided with the necessary approaches for diabetic foot ulcer care and exercises suitable for the physical condition of the wound and the patient, in addition to diaphragmatic breathing exercises. This group will also work with a physiotherapist twice a week.
Experimental: aerobic exercise group
The group performing aerobic exercise with a bicycle ergometer
The aerobic exercise group will be provided with the necessary approaches for diabetic foot ulcer care and in addition to diaphragmatic breathing exercises, they will be provided with aerobic exercise twice a week with a physiotherapist.
Experimental: control group
The group to which standard applications of DFU treatment will be applied
The control group will be provided with the necessary approaches for diabetic foot ulcer care and diaphragmatic breathing exercises.
Other Names:
  • control

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
ulcer area (mm²)
Time Frame: initial assessment- 4th week- 8th week- 12th week
Calculation of ulcer area with image j program
initial assessment- 4th week- 8th week- 12th week
ulcer depth (mm)
Time Frame: initial assessment - 12th week
Ulcer depth measurement with sterile wound stick
initial assessment - 12th week

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
quality of life score
Time Frame: initial assessment - 12th week
Investigation of patients' quality of life with Ferrans&Powers quality of life index
initial assessment - 12th week
sleep quality score
Time Frame: initial assessment - 12th week
investigating the sleep quality of patients with the Pittsburgh sleep quality index
initial assessment - 12th week

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
kinesiophobia score
Time Frame: initial assessment - 12th week
Investigation of patients' fear of movement with TAMPA
initial assessment - 12th week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2022

Primary Completion (Actual)

February 1, 2023

Study Completion (Actual)

July 1, 2023

Study Registration Dates

First Submitted

June 6, 2022

First Submitted That Met QC Criteria

June 16, 2022

First Posted (Actual)

June 21, 2022

Study Record Updates

Last Update Posted (Actual)

July 19, 2023

Last Update Submitted That Met QC Criteria

July 18, 2023

Last Verified

July 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Diabetic Foot Ulcer

Clinical Trials on exercise protocol

3
Subscribe